Kindred Biosciences Inc (NASDAQ:KIN)

9.13
Delayed Data
As of Jul 23
 -0.04 / -0.44%
Today’s Change
3.20
Today|||52-Week Range
9.28
+111.83%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$412.9M

Company Description

Kindred Biosciences, Inc. is a development-stage biopharmaceutical company, which focuses on saving and improving the lives of pets. The company was founded by Richard Chin and Denise M. Bevers on September 25, 2012 and is headquartered in Burlingame, CA.

Contact Information

Kindred Biosciences, Inc.
1555 Bayshore Highway
Burlingame California 94010
P:(650) 701-7901
Investor Relations:

Employees

Shareholders

Other institutional63.17%
Individual stakeholders21.98%
Mutual fund holders20.65%

Top Executives

Richard H. ChinPresident, Chief Executive Officer & Director
Wendy WeeSecretary, Chief Financial & Accounting Officer
Hangjun ZhanChief Scientific Officer
Russell RadefeldVP-Information Technology & Digital Marketing
Jay PetersonSenior Director-Biomanufacturing